{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:36:45Z","timestamp":1767109005800,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002985","name":"Delhi Technological University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002985","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12026-022-09288-7","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T21:02:37Z","timestamp":1652475757000},"page":"441-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thyroid receptor \u03b2 might be responsible for breast cancer associated with Hashimoto\u2019s thyroiditis: a new insight into pathogenesis"],"prefix":"10.1007","volume":"70","author":[{"given":"Muskaan","family":"Dhingra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayon","family":"Mahalanobis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-1005","authenticated-orcid":false,"given":"Asmita","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,13]]},"reference":[{"doi-asserted-by":"publisher","unstructured":"Rahman S, et al. Molecular insights into the relationship between autoimmune thyroid diseases and breast cancer: a critical perspective on autoimmunity and ER stress. Front Immunol. 2019 10 MAR\u00a0https:\/\/doi.org\/10.3389\/fimmu.2019.00344.","key":"9288_CR1","DOI":"10.3389\/fimmu.2019.00344"},{"issue":"AUG","key":"9288_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2018.00471","volume":"9","author":"C Giuliani","year":"2018","unstructured":"Giuliani C, Bucci I, Napolitano G. The role of the transcription factor nuclear factor-kappa B in thyroid autoimmunity. Front Endocrinol (Lausanne). 2018;9(AUG):1\u20138. https:\/\/doi.org\/10.3389\/fendo.2018.00471.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"9288_CR3","doi-asserted-by":"publisher","first-page":"101367","DOI":"10.1016\/j.beem.2019.101367","volume":"33","author":"F Ragusa","year":"2019","unstructured":"Ragusa F, et al. Hashimotos\u2019 thyroiditis: epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101367. https:\/\/doi.org\/10.1016\/j.beem.2019.101367.","journal-title":"Best Pract. Res Clin Endocrinol Metab"},{"issue":"4\u20135","key":"9288_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4\u20135):391\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.007","journal-title":"Autoimmun Rev"},{"issue":"10101","key":"9288_CR5","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(17)30703-1.","journal-title":"Lancet"},{"key":"9288_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DDDT.S12894","volume":"6","author":"B Vaidya","year":"2011","unstructured":"Vaidya B. Chakera, and Pearce, Treatment for primary hypothyroidism: current approaches and future possibilities. Drug Des Devel Ther. 2011;6:1. https:\/\/doi.org\/10.2147\/DDDT.S12894.","journal-title":"Drug Des Devel Ther"},{"issue":"23","key":"9288_CR7","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1001\/jama.2015.16535","volume":"314","author":"HB Burch","year":"2015","unstructured":"Burch HB, Cooper DS. Management of Graves disease. JAMA. 2015;314(23):2544. https:\/\/doi.org\/10.1001\/jama.2015.16535.","journal-title":"JAMA"},{"doi-asserted-by":"publisher","unstructured":"Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6 https:\/\/doi.org\/10.1186\/1743-422X-6-5","key":"9288_CR8","DOI":"10.1186\/1743-422X-6-5"},{"issue":"S 04","key":"9288_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0029-1211936","volume":"105","author":"TP Foley","year":"2009","unstructured":"Foley TP, Charron M. Radioiodine treatment of juvenile Graves disease. Exp Clin Endocrinol Diabetes. 2009;105(S 04):61\u20135. https:\/\/doi.org\/10.1055\/s-0029-1211936.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"12","key":"9288_CR10","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1210\/jc.2012-2802","volume":"97","author":"HB Burch","year":"2012","unstructured":"Burch HB, Burman KD, Cooper DS. A 2011 survey of clinical practice patterns in the management of Graves\u2019 disease. J Clin Endocrinol Metab. 2012;97(12):4549\u201358. https:\/\/doi.org\/10.1210\/jc.2012-2802.","journal-title":"J Clin Endocrinol Metab"},{"key":"9288_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/14651858.CD010576.pub2","volume":"2015","author":"ZW Liu","year":"2015","unstructured":"Liu ZW, Masterson L, Fish B, Jani P, Chatterjee K. Thyroid surgery for Graves\u2019 disease and Graves\u2019 ophthalmopathy. Cochrane Database Syst Rev. 2015;2015:11. https:\/\/doi.org\/10.1002\/14651858.CD010576.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"9288_CR12","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli M, et al. Autoimmunity reviews Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649 https:\/\/doi.org\/10.1016\/j.autrev.2020.102649","journal-title":"Autoimmun. Rev."},{"unstructured":"Y H Dong D Fu, Autoimmune thyroid disease: mechanism, genetics and current knowledge, pp. 3611\u20133618, 2014.","key":"9288_CR13"},{"issue":"19","key":"9288_CR14","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1038\/sj.onc.1210936","volume":"27","author":"E Porlan","year":"2008","unstructured":"Porlan E, Vidaurre OG, Rodr\u00edguez-Pe\u00f1a A. Thyroid hormone receptor-\u03b2 (TR\u03b21) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2. Oncogene. 2008;27(19):2795\u2013800. https:\/\/doi.org\/10.1038\/sj.onc.1210936.","journal-title":"Oncogene"},{"doi-asserted-by":"crossref","unstructured":"C. Gouveia, L Capelo, B Neofiti-Papi, A Zallone, Thyroid and bone. Elsevier Inc., 2020.","key":"9288_CR15","DOI":"10.1016\/B978-0-12-801238-3.11227-9"},{"issue":"6","key":"9288_CR16","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1073\/pnas.0510849103","volume":"103","author":"F Furuya","year":"2006","unstructured":"Furuya F, Hanover JA, Cheng SY. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone \u03b2 receptor. Proc Natl Acad Sci U S A. 2006;103(6):1780\u20135. https:\/\/doi.org\/10.1073\/pnas.0510849103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"9288_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/1541-7786.MCR-20-0282","volume":"18","author":"EL Bolf","year":"2020","unstructured":"Bolf EL, et al. Thyroid hormone receptor beta induces a tumor-suppressive program in anaplastic thyroid cancer. Mol Cancer Res. 2020;18(10):1443\u201352. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0282.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"9288_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvab102","volume":"5","author":"CD Davidson","year":"2021","unstructured":"Davidson CD, Bolf EL, Gillis NE, Cozzens LM, Tomczak JA, Carr FE. Thyroid hormone receptor beta inhibits PI3K-Akt-mTOR signaling axis in anaplastic thyroid cancer via genomic mechanisms. J Endocr Soc. 2021;5(8):1\u201314. https:\/\/doi.org\/10.1210\/jendso\/bvab102.","journal-title":"J Endocr Soc"},{"issue":"11","key":"9288_CR19","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1210\/en.2010-0475","volume":"151","author":"CJ Guigon","year":"2010","unstructured":"Guigon CJ, Kim DW, Zhu X, Zhao L, Cheng SY. Tumor suppressor action of liganded thyroid hormone receptor \u03b2 by direct repression of \u03b2-catenin gene expression. Endocrinology. 2010;151(11):5528\u201336. https:\/\/doi.org\/10.1210\/en.2010-0475.","journal-title":"Endocrinology"},{"issue":"10","key":"9288_CR20","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.3390\/ijms21103554","volume":"21","author":"Y-C Liu","year":"2020","unstructured":"Liu Y-C, Yeh C-T, Lin K-H. Molecular functions of thyroid hormone signaling in regulation of cancer progression and anti-apoptosis. In J Mol Sci 2019 20 4986. 2020;21(10):3554. https:\/\/doi.org\/10.3390\/ijms21103554.","journal-title":"In. J Mol Sci 2019 20 4986"},{"issue":"8","key":"9288_CR21","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1210\/en.2015-2046","volume":"157","author":"FE Carr","year":"2016","unstructured":"Carr FE, et al. Thyroid hormone receptor-\u03b2 (TR\u03b2) mediates runt-related transcription factor 2 (Runx2) expression in thyroid cancer cells: a novel signaling pathway in thyroid cancer. Endocrinology. 2016;157(8):3278\u201392. https:\/\/doi.org\/10.1210\/en.2015-2046.","journal-title":"Endocrinology"},{"issue":"4","key":"9288_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1158\/1055-9965.EPI-18-0877","volume":"28","author":"EL Bolf","year":"2019","unstructured":"Bolf EL, Sprague BL, Carr FE. A linkage between thyroid and breast cancer: a common etiology? Cancer Epidemiol Biomarkers Prev. 2019;28(4):643\u20139. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0877.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"9288_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40291-015-0175-y","volume":"20","author":"Z Nozhat","year":"2016","unstructured":"Nozhat Z, Hedayati M. PI3K\/AKT pathway and its mediators in thyroid carcinomas. Mol Diagnosis Ther. 2016;20(1):13\u201326. https:\/\/doi.org\/10.1007\/s40291-015-0175-y.","journal-title":"Mol Diagnosis Ther"},{"issue":"12","key":"9288_CR24","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K. The many faces and functions of \u03b2-catenin. EMBO J. 2012;31(12):2714\u201336. https:\/\/doi.org\/10.1038\/emboj.2012.150.","journal-title":"EMBO J"},{"issue":"1","key":"9288_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang X. Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165. https:\/\/doi.org\/10.1186\/s13045-020-00990-3.","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"9288_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ydbio.2017.01.003","volume":"422","author":"S Skah","year":"2017","unstructured":"Skah S, Uchuya-Castillo J, Sirakov M, Plateroti M. The thyroid hormone nuclear receptors and the Wnt\/\u03b2-catenin pathway: an intriguing liaison. Dev Biol. 2017;422(2):71\u201382. https:\/\/doi.org\/10.1016\/j.ydbio.2017.01.003.","journal-title":"Dev Biol"},{"issue":"6","key":"9288_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0127072","volume":"10","author":"S Heublein","year":"2015","unstructured":"Heublein S, et al. Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways. PLoS ONE. 2015;10(6):1\u201319. https:\/\/doi.org\/10.1371\/journal.pone.0127072.","journal-title":"PLoS ONE"},{"issue":"1","key":"9288_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12672-019-00373-2","volume":"11","author":"EL Bolf","year":"2020","unstructured":"Bolf EL, et al. The thyroid hormone receptor-RUNX2 axis: a novel tumor suppressive pathway in breast cancer. Horm Cancer. 2020;11(1):34\u201341. https:\/\/doi.org\/10.1007\/s12672-019-00373-2.","journal-title":"Horm Cancer"},{"key":"9288_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.39.1.295","volume":"39","author":"DG Johnson","year":"1999","unstructured":"Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999;39:295\u2013312. https:\/\/doi.org\/10.1146\/annurev.pharmtox.39.1.295.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"17","key":"9288_CR30","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1038\/sj.onc.1208618","volume":"24","author":"A Deshpande","year":"2005","unstructured":"Deshpande A, Sicinski P, Hinds PW. Cyclins and cdks in development and cancer: a perspective. Oncogene. 2005;24(17):2909\u201315. https:\/\/doi.org\/10.1038\/sj.onc.1208618.","journal-title":"Oncogene"},{"issue":"1","key":"9288_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1083\/jcb.201305084","volume":"204","author":"A Zambrano","year":"2014","unstructured":"Zambrano A, et al. The thyroid hormone receptor \u03b2 induces DNA damage and premature senescence. J Cell Biol. 2014;204(1):129\u201346. https:\/\/doi.org\/10.1083\/jcb.201305084.","journal-title":"J Cell Biol"},{"issue":"3","key":"9288_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-018-4844-5","volume":"171","author":"KJ Jerzak","year":"2018","unstructured":"Jerzak KJ, et al. Thyroid hormone receptor beta-1 expression in early breast cancer: a validation study. Breast Cancer Res Treat. 2018;171(3):709\u201317. https:\/\/doi.org\/10.1007\/s10549-018-4844-5.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"9288_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cancergencyto.2009.09.010","volume":"196","author":"Y Ling","year":"2010","unstructured":"Ling Y, et al. Aberrant methylation of the THRB gene in tissue and plasma of breast cancer patients. Cancer Genet Cytogenet. 2010;196(2):140\u20135. https:\/\/doi.org\/10.1016\/j.cancergencyto.2009.09.010.","journal-title":"Cancer Genet Cytogenet"},{"key":"9288_CR34","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2147\/OTT.S93418","volume":"8","author":"Y Ling","year":"2015","unstructured":"Ling Y, Ling X, Fan L, Wang Y, Li Q. Mutation analysis underlying the downregulation of the thyroid hormone receptor \u03b21 gene in the Chinese breast cancer population. Onco Targets Ther. 2015;8:2967\u201372. https:\/\/doi.org\/10.2147\/OTT.S93418.","journal-title":"Onco Targets Ther"},{"issue":"11","key":"9288_CR35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.7150\/ijbs.21635","volume":"13","author":"YS Sun","year":"2017","unstructured":"Sun YS, et al. Risk factors and preventions of breast cancer. Int J Biol Sci. 2017;13(11):1387\u201397. https:\/\/doi.org\/10.7150\/ijbs.21635.","journal-title":"Int J Biol Sci"},{"issue":"SUPPL. 2","key":"9288_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/modpathol.2010.56","volume":"23","author":"IO Ellis","year":"2010","unstructured":"Ellis IO. Intraductal proliferative lesions of the breast: morphology, associated risk and molecular biology. Mod Pathol. 2010;23(SUPPL. 2):1\u20137. https:\/\/doi.org\/10.1038\/modpathol.2010.56.","journal-title":"Mod Pathol"},{"issue":"11","key":"9288_CR37","first-page":"810","volume":"3","author":"V Parthasarathy","year":"2012","unstructured":"Parthasarathy V, Rathnam U. Nipple discharge: an early warning sign of breast cancer. Int J Prev Med. 2012;3(11):810\u20134.","journal-title":"Int J Prev Med"},{"issue":"1","key":"9288_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/1117-6806.169822","volume":"22","author":"O Egwuonwu","year":"2016","unstructured":"Egwuonwu O, Anyanwu S, Chianakwana G, E,. Ihekwoaba, Breast pain: clinical pattern and aetiology in a breast clinic in Eastern Nigeria. Niger J Surg. 2016;22(1):9. https:\/\/doi.org\/10.4103\/1117-6806.169822.","journal-title":"Niger. J. Surg."},{"issue":"23","key":"9288_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/ijms20236047","volume":"20","author":"R Zaj\u0105czkowska","year":"2019","unstructured":"Zaj\u0105czkowska R, Kocot-K\u0119pska M, Leppert W, Wordliczek J. Bone pain in cancer patients: mechanisms and current treatment. Int J Mol Sci. 2019;20(23):65\u201375. https:\/\/doi.org\/10.3390\/ijms20236047.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"9288_CR40","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0039-6109(16)45228-X","volume":"70","author":"MP Osborne","year":"1990","unstructured":"Osborne MP, Borgen PI. Role of mastectomy in breast cancer. Surg Clin North Am. 1990;70(5):1023\u201346. https:\/\/doi.org\/10.1016\/S0039-6109(16)45228-X.","journal-title":"Surg Clin North Am"},{"issue":"3","key":"9288_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10549-015-3354-y","volume":"150","author":"G Gu","year":"2015","unstructured":"Gu G, et al. Targeting thyroid hormone receptor beta in triple-negative breast cancer. Breast Cancer Res Treat. 2015;150(3):535\u201345. https:\/\/doi.org\/10.1007\/s10549-015-3354-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"9288_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm11030687","volume":"11","author":"IA Voutsadakis","year":"2022","unstructured":"Voutsadakis IA. The TSH\/thyroid hormones axis and breast cancer. J Clin Med. 2022;11(3):1\u201313. https:\/\/doi.org\/10.3390\/jcm11030687.","journal-title":"J Clin Med"},{"issue":"2","key":"9288_CR43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1158\/0008-5472.CAN-08-2198","volume":"69","author":"O Mart\u00ednez-Iglesias","year":"2009","unstructured":"Mart\u00ednez-Iglesias O, et al. Thyroid hormone receptor \u03b21 acts as a potent suppressor of tumor invasiveness and metastasis. Cancer Res. 2009;69(2):501\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2198.","journal-title":"Cancer Res"},{"issue":"1","key":"9288_CR44","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/thy.2019.0175","volume":"30","author":"I L\u00f3pez-Mateo","year":"2020","unstructured":"L\u00f3pez-Mateo I, et al. Thyroid hormone receptor \u03b2 inhibits self-renewal capacity of breast cancer stem cells. Thyroid. 2020;30(1):116\u201332. https:\/\/doi.org\/10.1089\/thy.2019.0175.","journal-title":"Thyroid"},{"issue":"2","key":"9288_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5152\/tjbh.2015.2462","volume":"11","author":"T Ozmen","year":"2015","unstructured":"Ozmen T, Gulluoglu BM, Yegen CS, Soran A. Autoimmune thyroid disease and breast cancer prognosis. J Breast Heal. 2015;11(2):67\u201371. https:\/\/doi.org\/10.5152\/tjbh.2015.2462.","journal-title":"J Breast Heal"},{"key":"9288_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2144\/fsoa-2021-0029","volume":"7","author":"G Graceffa","year":"2021","unstructured":"Graceffa G, et al. Breast cancer in previously thyroidectomized patients: which thyroid disorders are a risk factor? Futur Sci OA. 2021;7:5. https:\/\/doi.org\/10.2144\/fsoa-2021-0029.","journal-title":"Futur Sci OA"},{"issue":"1","key":"9288_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10549-020-05675-6","volume":"182","author":"L Bach","year":"2020","unstructured":"Bach L, Kostev K, Schiffmann L, Kalder M. Association between thyroid gland diseases and breast cancer: a case\u2013control study. Breast Cancer Res Treat. 2020;182(1):207\u201313. https:\/\/doi.org\/10.1007\/s10549-020-05675-6.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"9288_CR48","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3275\/7141","volume":"34","author":"I Muller","year":"2011","unstructured":"Muller I, et al. High prevalence of breast cancer in patients with benign thyroid diseases. J Endocrinol Invest. 2011;34(5):349\u201352. https:\/\/doi.org\/10.3275\/7141.","journal-title":"J Endocrinol Invest"},{"key":"9288_CR49","doi-asserted-by":"publisher","first-page":"92496","DOI":"10.1038\/bjc.2013.597","volume":"109","author":"Y-K Chen","year":"2013","unstructured":"Chen Y-K, Lin C-L, Cheng FT-F, Sung F-C, Kao C-H. Cancer risk in patients with Hashimoto\u2019s thyroiditis: a nationwide cohort study. Br J Cancer. 2013;109:92496\u2013501. https:\/\/doi.org\/10.1038\/bjc.2013.597.","journal-title":"Br J Cancer"},{"issue":"6","key":"9288_CR50","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1530\/EJE-15-0617","volume":"173","author":"I Ates","year":"2015","unstructured":"Ates I, Yilmaz FM, Altay M, Yilmaz N, Berker D, G\u00fcler S. The relationship between oxidative stress and autoimmunity in Hashimoto\u2019s thyroiditis. Eur J Endocrinol. 2015;173(6):791\u20139. https:\/\/doi.org\/10.1530\/EJE-15-0617.","journal-title":"Eur J Endocrinol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-022-09288-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-022-09288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T14:34:55Z","timestamp":1657550095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-022-09288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,13]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["9288"],"URL":"https:\/\/doi.org\/10.1007\/s12026-022-09288-7","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"type":"print","value":"0257-277X"},{"type":"electronic","value":"1559-0755"}],"subject":[],"published":{"date-parts":[[2022,5,13]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study does not contain any human participants or animals and has been carried out in the Department of Biotechnology, Delhi Technological University, following all ethical principles of the university.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}